EA199600078A1 - Новый хелатообразователь железа как ингибитор процесса окисления, опосредованного железом - Google Patents

Новый хелатообразователь железа как ингибитор процесса окисления, опосредованного железом

Info

Publication number
EA199600078A1
EA199600078A1 EA199600078A EA199600078A EA199600078A1 EA 199600078 A1 EA199600078 A1 EA 199600078A1 EA 199600078 A EA199600078 A EA 199600078A EA 199600078 A EA199600078 A EA 199600078A EA 199600078 A1 EA199600078 A1 EA 199600078A1
Authority
EA
Eurasian Patent Office
Prior art keywords
iron
exochelins
inhibitor
novel
mediated oxidation
Prior art date
Application number
EA199600078A
Other languages
English (en)
Other versions
EA000176B1 (ru
Inventor
Лоренс Хорвиц
Маркус А. Хорвиц
Бредфорд В. Гибсон
Джозеф Рив
Original Assignee
Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния filed Critical Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния
Publication of EA199600078A1 publication Critical patent/EA199600078A1/ru
Publication of EA000176B1 publication Critical patent/EA000176B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium
    • Y10S435/864—Mycobacterium avium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium
    • Y10S435/865—Mycobacterium fortuitum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium
    • Y10S435/866—Mycobacterium smegmatis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Dentistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Detergent Compositions (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Предложены экзохелины, которые могут быть использованы для предотвращения разрушения живой ткани из-за присутствия или образования (-OH) радикалов. В частности, изобретение направлено на введение экзохелинов в миокард, пораженный инфарктом, до или одновременно с реперфузией для предотвращения разрушения миокарда из-за опосредованного железом образования свободных радикалов. Кроме того, представлена химическая структура экзохелинов и модифицированных экзохелинов, а также применение этих материалов для лечения и диагностики заболеваний у млекопитающих. Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199600078A 1995-02-03 1996-01-26 Хелатообразователь железа в качестве ингибитора процесса окисления, опосредованного железом EA000176B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/383,180 US5721209A (en) 1995-02-03 1995-02-03 Iron chelator and inhibitor of iron-mediated oxidant injury
PCT/IB1996/000171 WO1996023502A1 (en) 1995-02-03 1996-01-26 Novel iron chelator as inhibitor of iron-mediated oxidation

Publications (2)

Publication Number Publication Date
EA199600078A1 true EA199600078A1 (ru) 1997-09-30
EA000176B1 EA000176B1 (ru) 1998-12-24

Family

ID=23512050

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199600078A EA000176B1 (ru) 1995-02-03 1996-01-26 Хелатообразователь железа в качестве ингибитора процесса окисления, опосредованного железом

Country Status (13)

Country Link
US (1) US5721209A (ru)
EP (1) EP0754044B1 (ru)
JP (1) JP3511139B2 (ru)
KR (1) KR100325970B1 (ru)
CN (1) CN1209110C (ru)
AT (1) ATE330610T1 (ru)
AU (1) AU699916B2 (ru)
CZ (1) CZ288996A3 (ru)
DE (1) DE69636267T2 (ru)
EA (1) EA000176B1 (ru)
HU (1) HUP9603036A3 (ru)
PL (1) PL182414B1 (ru)
WO (1) WO1996023502A1 (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837677A (en) * 1995-02-03 1998-11-17 Keystone Biomedical, Inc. Method for the treatment of cancer with Exochelins of Mycobacterium tuberculosis
US5786326A (en) * 1995-02-03 1998-07-28 Horwitz; Lawrence D. Method for the treatment of atherosclerosis and vascular injury by prevention of vascular smooth muscle cell proliferation
US5994346A (en) * 1995-02-03 1999-11-30 Regents Of The University Of California Use of exochelins in the preservation of organs for transplant
US6054133A (en) * 1997-07-10 2000-04-25 The Regents Of The University Of California Anti-microbial targeting for intracellular pathogens
US5952492A (en) * 1998-08-14 1999-09-14 Keystone Biomedical, Inc. Chemical synthesis of exochelins
US6063919A (en) * 1998-08-14 2000-05-16 Keystone Biomedical, Inc. Process for the synthesis of exochelins
US6933104B1 (en) * 1999-04-23 2005-08-23 Shiva Biomedical, Llc Diagnosis and treatment of human kidney diseases
US6486199B1 (en) 2001-06-21 2002-11-26 Medicines For Malaria Venture Mmv International Centre Cointrin Spiro and dispiro 1,2,4-trioxolane antimalarials
US6906205B2 (en) * 2002-06-21 2005-06-14 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US20080125441A1 (en) * 2002-06-21 2008-05-29 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US7371778B2 (en) * 2002-06-21 2008-05-13 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US8067620B2 (en) * 2005-05-04 2011-11-29 Medicines For Malaria Venture Mmv Dispiro 1,2,4-trioxolane antimalarials
GB0526033D0 (en) 2005-12-21 2006-02-01 Bioeos Ltd Method

Also Published As

Publication number Publication date
HU9603036D0 (en) 1997-01-28
EP0754044B1 (en) 2006-06-21
DE69636267D1 (de) 2006-08-03
KR100325970B1 (ko) 2002-07-27
PL182414B1 (pl) 2001-12-31
CN1209110C (zh) 2005-07-06
HUP9603036A2 (en) 1997-05-28
EA000176B1 (ru) 1998-12-24
WO1996023502A1 (en) 1996-08-08
EP0754044A1 (en) 1997-01-22
AU699916B2 (en) 1998-12-17
DE69636267T2 (de) 2008-07-31
CN1145588A (zh) 1997-03-19
AU4674496A (en) 1996-08-21
JP3511139B2 (ja) 2004-03-29
PL316612A1 (en) 1997-01-20
CZ288996A3 (en) 1997-04-16
ATE330610T1 (de) 2006-07-15
MX9604499A (es) 1997-11-29
HUP9603036A3 (en) 2000-07-28
US5721209A (en) 1998-02-24

Similar Documents

Publication Publication Date Title
EA199600078A1 (ru) Новый хелатообразователь железа как ингибитор процесса окисления, опосредованного железом
DK308684A (da) Enzympraeparat til rensningsformaal
DE60236413D1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
DE69716647T2 (de) Biologische behandlung von gebrauchten kaustischen laugen
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200000920A1 (ru) Производные бициклических гидроксамовых кислот
EA199900778A1 (ru) ГЕТЕРОЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ И ИХ ИСПОЛЬЗОВАНИЕ ДЛЯ ИНГИБИРОВАНИЯ β-АМИЛОИДНОГО ПЕПТИДА
EA199900494A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200201214A1 (ru) Замещенные тиоацетамиды
EA200200904A1 (ru) Структуры в растворе и в кристалле активного центра ммр-13 и их применение
EA200001223A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
DE69822665D1 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
EA199800563A1 (ru) Антагонисты гормона, высвобождающего гонадотропин
EA200100589A1 (ru) Азабициклоалканы как модуляторы ccr5
ATE422556T1 (de) Hdac4- und hdac5-abhängige regulation der genexpression im herzen
EA200200390A1 (ru) Новые оксабиспидиновые соединения, полезные при лечении сердечных аритмий
EA200301253A1 (ru) Применение остеопонтина для лечения и/или профилактики неврологических заболеваний
FR2450107A1 (fr) Nouvelles compositions detergentes cosmetiques et pharmaceutiques a base de sarcosine
EA200100264A1 (ru) Ангиоцидин: адгезионный рецептор опухолей клетки, специфический для cys-ser-val-thr-cys-gly
DK0408371T3 (da) Hæmoregulatoriske peptider
SE9904674D0 (sv) Novel compounds
EA200100297A1 (ru) Моногидрат гидробромида элетриптана
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
DE69716914D1 (de) Behandlung und prophylaxe von unerwünschten effekten reaktiver sauerstoffverbindungen
FR2410658A1 (fr) Nouveau produit biologique d'origine fongique, son obtention et son application a la therapeutique

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ KZ KG TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU